Hypothalamic Hamartoma and Endocrinopathy: A Neurosurgeon's Perspective

Area of Science:

• Neurosurgery
• Pediatric Endocrinology
• Neurology

Background:

• Hypothalamic hamartomas (HH) are rare congenital benign lesions.
• They commonly present with drug-refractory epilepsy (DRE) and/or central precocious puberty (CPP).
• Management strategies are tailored to the specific clinical presentation.

Purpose of the Study:

• To report on the neurosurgical management of hypothalamic hamartomas.
• To emphasize the endocrine abnormalities associated with HH.
• To evaluate the efficacy of robotic-guided radiofrequency ablation (RFA).

Main Methods:

• A prospective observational study included 16 pediatric patients with HH.
• Evaluations included 3 Tesla MRI, comprehensive hormonal workup, and video-electroencephalography (VEEG).
• Robotic-guided radiofrequency ablation (RFA) was the primary intervention.

Main Results:

• All 16 patients presented with DRE; 4 also had CPP.
• Robotic-guided RFA achieved 75% seizure freedom after the first procedure.
• Three of four CPP patients experienced clinical and biochemical normalization post-RFA.

Conclusions:

• Individualized management of HH is crucial, prioritizing DRE treatment with early surgical intervention.
• A multidisciplinary approach is recommended for optimal outcomes in managing hypothalamic hamartomas.
• Robotic-guided RFA demonstrates efficacy in treating DRE and associated endocrine dysfunction in HH.